Memantine Hydrochloride Tablet
Product Images NDC 63629-2512

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 63629-2512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 01)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 02)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 03)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 04)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 05)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 06)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 07)

The text appears to be a graph showing the Cumulative Percentage of Patients for two different medications, Placobol/Donopozil and M. HClDonepezil, with a range depicted on the x-axis (-10 to 20) and the percentage of patients on the y-axis (up to 100%). The graph also includes a line showing the ADCS-ADL Change from Baseline, with a value of 25.*

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 08)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 09)

The text shows a graph representing the cumulative percentage of patients with SIB (Severe Impairment Battery) change from baseline while being treated with either placebo/donepezil or memantine hydrochloride/donepezil. The X-axis shows the SIB change from baseline ranging from -15 to 25, and the Y-axis represents the cumulative percentage of patients ranging from 0 to 100.*

FDA Label Image

Label (Lbl636292512)

NILD Pharmaceuticals' Memantine Hydrochloride Tablets are used to treat Alzheimer's disease. Each tablet contains 10 mg of Memantine Hydrochloride, which should be kept out of reach of children and stored in a tight container at 20°C to 25°C. The drug is available in 60-tablet packs with an NDC code of 63629-2512-1. This medicine is only available with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.